Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma
Charles Marusak(University of Miami), Barbara Bedogni(Stanford University)
Cited by 44
Related Papers
Notch1 is an effector of Akt and hypoxia in melanoma development
|Journal of Clinical Investigation|2008|207
Noncanonical Activation of Notch1 Protein by Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Controls Melanoma Cell Proliferation
|Journal of Biological Chemistry|2014|37
MT1-MMP-dependent ECM processing regulates laminB1 stability and mediates replication fork restart
|PLoS ONE|2021|12
Notch1 blockade by a novel, selective anti-Notch1 neutralizing antibody improves immunotherapy efficacy in melanoma by promoting an inflamed TME
|Journal of Experimental & Clinical Cancer Research|2024|4
Co-inhibition of Notch1 and ChK1 triggers genomic instability and melanoma cell death increasing the lifespan of mice bearing melanoma brain metastasis
|Journal of Experimental & Clinical Cancer Research|2025|2